A comparative study of 14-day dual therapy (esomeprazole and amoxicillin four times daily) and triple plus bismuth therapy for first-line Helicobacter pylori infection eradication: A randomized trial.
Zhiqiang SongLi-Ya ZhouYan XueBaojun SuoXueli TianZhanyue NiuPublished in: Helicobacter (2020)
Dual therapy (esomeprazole and amoxicillin four times daily) was non-inferior to, and even superior to TPB therapy as first-line H pylori eradication.